Trial Profile
A phase I trial of CC-8490 for the treatment of patients with recurrent/refractory high-grade gliomas
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Mar 2009
Price :
$35
*
At a glance
- Drugs CC 8490 (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 09 Sep 2005 New trial record.